tag:blogger.com,1999:blog-14743001.post8179182962116513569..comments2024-01-02T02:45:17.328-06:00Comments on Notes from Dr. RW: Genomic dosing of warfarinRobert W Donnellhttp://www.blogger.com/profile/16944231400440786271noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-14743001.post-8091772905939516032014-02-07T06:47:26.983-06:002014-02-07T06:47:26.983-06:00It seems that the differences between the two stud...It seems that the differences between the two studies' findings can probably be attributed to the fact that the EU-PACT study used fixed-dosing of warfarin, while the COAG study used an algorithmic dosing approach based on a number of clinical variables known to affect warfarin response (age, ethnicity, whether the patient was also on amiodarone, etc.). <br /><br />The COAG trial was very Jonnoreply@blogger.com